CH614221A5 - - Google Patents

Info

Publication number
CH614221A5
CH614221A5 CH713175A CH713175A CH614221A5 CH 614221 A5 CH614221 A5 CH 614221A5 CH 713175 A CH713175 A CH 713175A CH 713175 A CH713175 A CH 713175A CH 614221 A5 CH614221 A5 CH 614221A5
Authority
CH
Switzerland
Application number
CH713175A
Inventor
Samuel Wilkinson
Roderick John Flower
Sergio Henrique Ferreira
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB24660/74A external-priority patent/GB1516642A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH614221A5 publication Critical patent/CH614221A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/46—Sulfates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Geology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH713175A 1974-06-04 1975-06-03 CH614221A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB24660/74A GB1516642A (en) 1974-06-04 1974-06-04 Biological reagent
GB5398674 1974-12-13

Publications (1)

Publication Number Publication Date
CH614221A5 true CH614221A5 (de) 1979-11-15

Family

ID=26257224

Family Applications (1)

Application Number Title Priority Date Filing Date
CH713175A CH614221A5 (de) 1974-06-04 1975-06-03

Country Status (12)

Country Link
US (1) US4110432A (de)
JP (1) JPS519714A (de)
AU (1) AU8180175A (de)
CH (1) CH614221A5 (de)
DE (1) DE2524637A1 (de)
DK (1) DK248775A (de)
ES (1) ES438163A1 (de)
FI (1) FI751633A (de)
FR (1) FR2273554A1 (de)
IL (1) IL47412A0 (de)
NL (1) NL7506560A (de)
SE (1) SE7506313L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188622C (nl) * 1981-12-15 1992-08-17 Cordis Europ Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film.
US4678671A (en) * 1981-12-15 1987-07-07 Cordis Europa N.V. Conjugates of anticoagulant and protein
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
EP0172962A1 (de) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandine
US5171563A (en) * 1988-09-30 1992-12-15 Neorx Corporation Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
DE68919366T2 (de) * 1988-09-30 1995-05-18 Neorx Corp Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.
US6007817A (en) * 1988-10-11 1999-12-28 University Of Southern California Vasopermeability enhancing immunoconjugates
EP0540670B1 (de) * 1990-07-26 1996-03-20 Monsanto Company Verfahren zur herstellung vernetzter polyamine
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
EP1615596B1 (de) * 2003-04-11 2016-11-02 Etex Corporation Osteoinduktives knochenmaterial
CA2562675A1 (en) * 2004-04-15 2005-12-15 Etex Corporation Delayed-setting calcium phosphate pastes
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3690834A (en) * 1971-01-11 1972-09-12 Syva Co Ligand determination with spin labeled compounds by receptor displacement
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies

Also Published As

Publication number Publication date
FI751633A (de) 1975-12-05
NL7506560A (nl) 1975-12-08
JPS519714A (de) 1976-01-26
US4110432A (en) 1978-08-29
ES438163A1 (es) 1977-05-16
IL47412A0 (en) 1975-08-31
FR2273554B1 (de) 1978-07-28
DE2524637A1 (de) 1976-01-02
AU8180175A (en) 1976-12-09
FR2273554A1 (fr) 1976-01-02
SE7506313L (sv) 1975-12-05
DK248775A (da) 1975-12-05

Similar Documents

Publication Publication Date Title
FR2271282A1 (de)
FR2262781B2 (de)
FR2264492B1 (de)
FR2268447A1 (de)
FR2285518B1 (de)
FR2267472B1 (de)
FR2273554B1 (de)
FI752998A (de)
FR2266659A1 (de)
FR2271074B1 (de)
DK72475A (de)
JPS50100203U (de)
AU495920B2 (de)
JPS49115942U (de)
AU7099174A (de)
AU7138274A (de)
JPS50103559A (de)
AU480580A (de)
AU481340A (de)
AU480209A (de)
AU480469A (de)
BG21805A1 (de)
AU481044A (de)
AU481082A (de)
BG22011A1 (de)

Legal Events

Date Code Title Description
PL Patent ceased